IP Library Granted Patent US 7,166,715
Granted Patent B2
US 7,166,715 · App. 10/840,189 · Granted Jan 23, 2007

Nitro-substituted non-fluorescent asymmetric cyanine dye compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,166,715
App. No.
10/840,189
Granted
Jan 23, 2007
Kind
B2
Abstract

The invention provides an asymmetric cyanine dye compound having the structure including substituted forms thereof, wherein, at least one of R 1 and R 2 is linking group, X is O, S, or Se, and n ranges from 0 to 2. The invention further provides reporter-quencher dye pairs comprising the asymmetric cyanine dyes, dye-labelled polynucleotides incorporating the asymmetric cyanine dyes, and hybridization detection methods utilizing the dye-labelled polynucleotides.

Claims (27)

1. A labelled oligonucleotide comprising:

an oligonucleotide; and

a reporter-quencher energy-transfer dye pair comprising a reporter dye and quencher dye wherein the quencher dye is an asymmetric cyanine dye compound having the structure:

and including any associated counter ions, wherein:

n ranges from 0 to 2;

X is O, S or Se;

R 1 is selected from the group consisting of methyl and a linking group, or when taken together with the proximate carbon of the methine bridge forms a ring structure having from 5 to 7 members;

R 2 is a linking group;

R 3 is hydrogen, or when taken together with R 4 forms a fused aromatic bridge substituted with one or more nitro groups;

R 4 is hydrogen, or when taken together with either R 3 or R 5 forms a fused aromatic bridge substituted with one or more nitro groups;

R 5 is nitro, or when taken together with either R 4 or R 6 forms a fused aromatic bridge substituted with one or more nitro groups; and

R 6 is hydrogen, or when taken together with either R 5 forms a fused aromatic bridge substituted with one or more nitro groups.

2. The labelled oligonucleotide of claim 1 in which the reporter dye is selected from the group consisting of xanthene, coumarin, naphthylamine, cyanine and bodipy dyes.

3. The labelled oligonucleotide of claim 2 in which the reporter dye is a xanthene dye.

4. The labelled oligonucleotide of claim 3 in which the xanthene dye is a fluorescein dye or a rhodamine dye.

5. The labelled oligonucleotide of claim 1 in which the reporter dye is 5- or 6-carboxy-fluorescein (FAM) and the quencher dye is of the formula:

6. The labelled oligonucleotide of claim 1 in which the reporter dye is selected from the group consisting of 5- or 6-carboxy-fluorescein (FAM), 2′,4′, 1,4-tetrachlorofluorescein (TET) and 2′-chloro-5′-fluoro-7′,8′-fused phenyl-1,4-dichloro-6-carboxyfluorescein (NED) and the quencher dye is of the formula:

7. The labelled oligonucleotide of claim 1 in which the quencher dye is of the formula:

8. The labelled oligonucleotide of claim 1 in which the quencher dye is of the formula:

9. The labelled oligonucleotide of claim 1 in which the quencher dye is of the formula:

10. The labelled oligonucleotide of claim 1 in which the quencher dye is of the formula:

11. The labelled oligonucleotide of claim 1 in which the quencher dye is of the formula:

12. The labelled oligonucleotide of claim 1 in which the quencher dye is of the formula:

13. The labelled oligonucleotide of claim 1 wherein the location of the reporter dye and the quencher dye is such that when the labelled oligonucleotide is hybridized to a target nucleic acid sequence the reporter dye is not effectively quenched by the quencher dye, and when the labelled oligonucleotide is not hybridized to a target nucleic acid sequence the reporter dye is effectively quenched by the quencher dye.

14. The labelled oligonucleotide of claim 1 wherein one of the reporter and quencher dyes is attached at a 3′ end of the oligonucleotide and the other is attached at a 5′-end of the oligonucleotide.

15. The labelled oligonucleotide of claim 1 wherein the oligonucleotide sequence is designed such that a hairpin forms at the ends.

16. The labelled oligonucleotide of claim wherein the oligonucleotide is cut by 5'—3'nuclease activity of a polymerase whereby the reporter dye and quencher dye are separated.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE THE RECEIVING PARTY NAME, PREVIOUSLY RECORDED ON REEL 030182 FRAME 0677. ASSIGNOR(S) HEREBY CONFIRMS THE THE RELEASE OF SECURITY INTEREST. Recorded Mar 4, 2016
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 037998/0507 →
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: APPLIED BIOSYSTEMS, INC.
Reel/Frame 030182/0677 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: APPLIED BIOSYSTEMS, LLC
To: BANK OF AMERICA, N.A, AS COLLATERAL AGENT
Reel/Frame 021976/0001 →